A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)
Clinical trial NCT06292780 · RECRUITING
Trial details
- NCT number
- NCT06292780
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-07
- Primary completion
- 2028-08-20
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.